| Literature DB >> 35453298 |
Vanessa Brinkmann1,2, Margherita Romeo1,2, Lucie Larigot3, Anne Hemmers2, Lisa Tschage2, Jennifer Kleinjohann2, Alfonso Schiavi1,2, Swantje Steinwachs2, Charlotte Esser2, Ralph Menzel4, Sara Giani Tagliabue5, Laura Bonati5, Fiona Cox1,6, Niloofar Ale-Agha1, Philipp Jakobs1, Joachim Altschmied1,2, Judith Haendeler1, Xavier Coumoul3, Natascia Ventura1,2.
Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor whose activity can be modulated by polyphenols, such as curcumin. AhR and curcumin have evolutionarily conserved effects on aging. Here, we investigated whether and how the AhR mediates the anti-aging effects of curcumin across species. Using a combination of in vivo, in vitro, and in silico analyses, we demonstrated that curcumin has AhR-dependent or -independent effects in a context-specific manner. We found that in Caenorhabditis elegans, AhR mediates curcumin-induced lifespan extension, most likely through a ligand-independent inhibitory mechanism related to its antioxidant activity. Curcumin also showed AhR-independent anti-aging activities, such as protection against aggregation-prone proteins and oxidative stress in C. elegans and promotion of the migratory capacity of human primary endothelial cells. These AhR-independent effects are largely mediated by the Nrf2/SKN-1 pathway.Entities:
Keywords: Caenorhabditis elegans; aryl hydrocarbon receptor; curcumin; endothelial cells; in silico; in vitro; in vivo; mice; oxidative stress
Year: 2022 PMID: 35453298 PMCID: PMC9024831 DOI: 10.3390/antiox11040613
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Curcumin promotes health in an AHR-1-dependent and -independent manner. Lifespan (A) and health span (B) curves of DMSO- or curcumin-treated wt and ahr-1 nematodes. Survival curves show pooled data of 290–300 worms/condition in 5 experiments. Statistical test: log-rank test, # significance vs. DMSO, * significance vs. wt, Bonferroni p-value < 0.05. (C) Quantification of aggregates in 10-day-old polyQ;wt and polyQ;ahr-1 (left panel) or 7-day-old asyn;wt and asyn;ahr-1 (right panel). Boxplots show pooled data from 59–111 worms/condition in 3 experiments. Statistical test: 1-way ANOVA with Tukey’s multiple comparisons test, * p-value < 0.05 vs. wt, # p-value < 0.05 vs. DMSO. (D,E) Life/health span of polyQ;wt and polyQ;ahr-1. Survival curves show pooled data of 180 worms/condition in 3 experiments. Statistical test: log-rank test, # significance vs. DMSO, * significance vs. wt, Bonferroni p-value < 0.05.
Figure 2Genes differentially regulated by curcumin are primarily regulated in an ahr-1-dependent manner. (A) Gene ontology (GO) enrichment for biological processes after GO term fusion in ahr-1 vs. wt. (B,C) The expression of the strongest down- and up-regulated genes between wt and ahr-1 [25] was assessed by qPCR in wt vs. ahr-1 (B) and DMSO- vs. curcumin-treated nematodes (C). Boxplots show data of 3 experiments. The expression is shown relative to DMSO-treated wt (dashed line). Statistical test: 1-way ANOVA with Tukey’s multiple comparisons test, * p-value < 0.05 vs. wt. (D) Venn diagram of differentially expressed genes on the microarray. The number of genes that were differentially up- or down-regulated between the indicated conditions is shown in red and blue, respectively. The numbers in the interchanges refer to the genes that occurred in both comparisons. The values in the lower right corner show the number of genes on the array that were not differentially expressed.
List of genes from the microarray analysis.
| Strongest Over-/Under-Expressed Genes by Curcumin in an | |||||
|---|---|---|---|---|---|
| Gene/Sequence Name | Gene Class a | Molecular Function a | logFC b | adj. | Selected Modulators a |
| H43E16.1 | unknown | unknown | 1.53 | 0.021 | bacterial infection, |
|
| Nuclear localized metal responsive | unknown | 1.42 | 0.034 | bacterial infection, |
|
| Mucin-like | unknown | 1.34 | 0.029 | resveratrol, |
|
| O-acyltransferase homolog | transferase activity, transferring acyl groups other than amino-acyl groups | 1.24 | 0.085 | bacterial infection, quercetin, tryptophan, |
| F58B4.5 | unknown | unknown | 1.21 | 0.030 | resveratrol, |
|
| Catechol-O-methyl-transferase | O-methyltransferase activity | 1.17 | 0.030 | pathogenic bacteria, |
| F09C8.1 | Ortholog of human phospholipase B1 | Phospholipase activity; | 1.08 | 0.030 | |
|
| UDP-glucuronosyl-transferase | calmodulin binding, glucuronosyltransferase activity, UDP-glycosyltransferase activity, transferase activity, transferring hexosyl and glycosyl groups | 1.07 | 0.034 | bacterial infection, rotenone, aging |
|
| Cytochrome P450 | monooxygenase activity, metal ion binding, heme binding, oxidoreductase activity | 1.05 | 0.057 | bacterial infection, quercetin, |
| T19C9.8 | unknown | unknown | 0.96 | 0.084 | bacterial infection, quercetin, |
|
| Lysozyme | unknown | −1.54 | 0.084 | bacterial infection, aging, rotenone, |
|
| Cytochrome P450 | monooxygenase activity, metal ion binding, heme binding, oxidoreductase activity, steroid hydroxylase activity | −1.08 | 0.087 | bacterial infection, |
| C14A4.9 | unknown | unknown | −0.55 | 0.079 | bacterial infection, quercetin, rotenone, indole |
|
| |||||
|
|
|
|
|
| |
|
| Solute carrier homolog | transmembrane transporter activity | 0.64 | 0.46 | |
|
| UDP-glucuronosyl-transferase | glucuronosyltransferase activity, transferase activity, transferring hexosyl groups | 0.57 | 0.41 | |
|
| Nuclear hormone receptor | metal ion binding, zinc ion binding, transcription factor activity, sequence-specific DNA binding | 0.43 | 0.39 | |
|
| UDP-glucuronosyl-transferase | glucuronosyltransferase activity, transferase activity, transferring hexosyl and glycosyl groups | 0.36 | 0.34 | |
| C14A4.9 | unknown | unknown | −0.55 | −0.63 | |
Extracted from Wormbase; LogFC: logarithmic fold change; Adj. p-value: adjusted p-value; logarithmic fold change wt curcumin vs. wt DMSO; logarithmic fold change ahr-1 DMSO vs. wt DMSO.
Figure 3ugt-45 is required for the lifespan extension of curcumin and ahr-1 mutants. (A,B) Gene expression was assessed by qPCR in wt vs. ahr-1 (A) and DMSO- vs. curcumin-treated wt nematodes (B). Boxplots show data of 3 experiments. The expression is shown relative to DMSO-treated wt (indicated as dashed line). Statistical test: 2-Way ANOVA with Sidak’s multiple comparisons test, * p-value < 0.05 vs. wt, # p-value < 0.05 vs. DMSO. (C,D) Effect of ugt-45 RNAi on the curcumin-mediated life/health span extension in the wt. Survival curves show pooled data of 120 worms/condition in 2 replicates. Statistical test: Log-Rank test, # significance vs. DMSO, * significance vs. control RNAi, Bonferroni p-value < 0.05. (E,F) Effect of ugt-45 RNAi on ahr-1-mediated life/health span extension. Survival curves show pooled data of 120 worms/condition in 2 replicates. Statistical test: Log-Rank test, # significance vs. wt, * significance vs. control RNAi, Bonferroni p-value < 0.05.
Figure 4AHR-1 and curcumin independently protect against oxidative stress. (A) Representative images (left) and DSRed intensity quantification (right) in MitoSOX-stained wt or ahr-1 nematodes. Boxplots show pooled data from 129–135 worms/condition in 3 experiments. (B) The mitochondria membrane potential was assessed by TRME staining in nematodes of indicated ages. Representative images (left) and the quantification of the TMRE fluorescence (right) are presented. Boxplots show pooled data from 3 experiments. (C,D) Pharyngeal pumping activity (C) and motility (D) of wt and ahr-1 mutants after H2O2 treatment. Boxplots show pooled data from 39–54 (C) or 35–36 worms/condition (D) in 3–4 experiments. * p-value < 0.05 vs. wt, $ p-value < 0.05 vs. control treatment, statistical test: 1-way ANOVA with Tukey’s multiple comparisons test. (E) Pharyngeal pumping of curcumin-treated nematodes after H2O2 treatment. Boxplots show pooled data from 32 worms/condition in 2 experiments. * p-value < 0.05 vs. wt, # p-value < 0.05 cur vs. DMSO treatment, $ p-value < 0.05 H2O2 vs. control statistical test: 2-way ANOVA with Tukey’s multiple comparisons test. (F) Influence of curcumin on juglone-induced toxicity. Survival curves show pooled data of 500 worms/condition in 20 experiments. * significance ahr-1 vs. wt, # significance curcumin vs. DMSO, Bonferroni p-value < 0.05. (G) Effect of ugt-45 RNAi in curcumin-fed wt and ahr-1 worms. Survival curves show pooled data of 150 worms/condition in 6 experiments. Statistical test: log-rank test, * significance ahr-1 vs. wt, # significance curcumin vs. DMSO, Bonferroni p-value < 0.05. No statistical significance was observed in ugt-45 vs. control RNAi-treated worms.
Figure 5Curcumin activates Nrf2/SKN-1 independent of the AhR. (A) Scratch wound assay in curcumin (cur)- or DMSO-treated human primary EC transfected with an empty vector (EV) or an expression vector for human AhR. Upper panel: representative pictures; the dashed line represents migration start. Scale bar: 100 µm. Lower panel: quantification; boxplots show data of 4–6 experiments. Statistical test: 1-way ANOVA, * p < 0.05 vs. EV, # p < 0.05 vs. DMSO. (B,C) Human primary EC were treated with cur or DMSO. (B) Representative immunostainings: AhR is stained in red, nuclei were visualized with DAPI (blue), the cytoskeleton is counterstained with phalloidin (green), merge shows an overlay of all fluorescence channels. In the negative control (- con), the first antibody was omitted, and cells were stained with Alexa 488-coupled phalloidin and DAPI. Scale bar: 50 µm. (C) Relative cyp1a1 expression was assessed by qPCR. Mean expression in the DMSO-treated controls was set to 1. Boxplots show data of 7 experiments. (D) Pgst-4:GFP expression in DMSO- and curcumin-treated (cur) wt and ahr-1 worms. Boxplots show pooled data of 118–138 worms/condition in 4 experiments. * p-value < 0.05 vs. wt, # p-value < 0.05 vs. DMSO treatment, statistical test: 1-way ANOVA. (E) Representative immunostaining images of human primary EC treated with cur or DMSO: Nrf2 is stained in red, nuclei were visualized with DAPI (blue), the cytoskeleton is counterstained with phalloidin (green), merge shows an overlay of all fluorescence channels. In the negative control (- con) the first antibody was omitted, and cells were stained with Alexa 488-coupled phalloidin and DAPI. Scale bar: 50 µm. (F) Human primary EC were transfected with an empty vector (EV) or an expression vector for an shRNA targeting the human AhR transcript (shAhR). Relative Sod2 expression was assessed by qPCR, mean expression in the EV transfected cells was set to 1. Boxplots show data of 7 experiments. # p < 0.05 vs. respective control. (G,H) Pgst-4::GFP expression in DMSO- or cur-treated wt and ahr-1 nematodes subjected to control or skn-1 RNAi. Representative images (G) and gst-4-driven GFP quantification (H) are shown. Boxplots show pooled data of 103–189 worms/condition in 4 experiments. (I) Juglone stress survival in curcumin- or DMSO-treated wt and ahr-1 nematodes subjected to control or skn-1 RNAi. Kaplan Meier survival curves show pooled data of 100 worms/condition in 4 experiments. Statistical test: log-rank test, * significance ahr-1 vs. wt, # significance curcumin vs. DMSO, $ significance skn-1 vs. con RNAi, Bonferroni p-value < 0.05.
Figure 6Curcumin and pro-oxidants have opposite effects on AHR-1 activity. (A–C) Evaluation of AHR-1 activity after treatment with the indicated compounds in Cos7 cells transfected with either wt AHR-1 (wt) or AHR-1 carrying the ju145 point mutation (ju145) and AHA-1 as well as an XRE-inducible luciferase. Boxplots show data of 3–5 experiments. * p-value < 0.05 vs. wt, # p-value < 0.05 vs. DMSO/EtOH, statistical test: 2-way ANOVA and Tukey’s multiple comparisons test. (D) Alignment of the LBDs from C. elegans, Drosophila, and zebrafish AhRs. The color scheme for residues: red, acidic; blue, basic; purple, polar; yellow, Cys; brown, aromatic; green, hydrophobic; orange, Ser, Thr; gray, Pro; white, Gly. (E) Secondary structures attributed by DSSPcont to the CeAhR PASB are indicated on top (light gray bars for helices and dark gray bars for β-strands) and labeled according to the PAS domain nomenclature. Asterisks mark the amino acids likely contributing to the inability of CeAhR to bind big ligands. Amino acids highlighted by an arrow were mutated for the investigation of the LBD function (panels F,H). I 3D models of the CeAhR (left) and the mAhR (right) PASB domains obtained by homology modeling, shown in a cartoon representation. Secondary structures attributed by DSSPcont are labeled according to the PAS domain nomenclature. The colored internal area (blue for CeAhR and yellow for mAhR) defines the molecular surface of the binding cavity identified by CASTp. In the CeAhR model, the amino acids protruding into the binding cavity (asterisks in panel D) are labeled and shown as blue sticks. The mAhR amino acids corresponding to those displayed in the CeAhR model, are labeled and shown as yellow sticks. Amino acids highlighted by an arrow were mutated for studying the LBD function (panels F,H). (F) AhR activity in BaP- or MNF-treated Cos7 cells transfected with either AHR-1, an AHR-1 with L363A and H365Q mutations (LBD mutant), or mouse AhR (mAhR), as well as AHA-1 and an XRE-driven luciferase. Boxplots show data of 3 experiments. Statistical analysis: 2-way ANOVA and Tukey’s multiple comparisons test. * p-value < 0.05 vs. wt, # p-value < 0.05 vs. DMSO. (G) Effect of rotenone on AhR activity in Cos7 cells transfected with AHR-1 (either wt or ju145) as well as AHA-1 and an XRE-driven luciferase. Boxplots show data of 3 experiments. Statistical analysis: 2-way ANOVA and Tukey’s multiple comparisons test. * p-value < 0.05 vs. wt, # p-value < 0.05 vs. DMSO. (H) Effect of rotenone on AhR activity in Cos7 cells transfected with either AHR-1, AHR-1 with L363A and H365Q mutations (LBD mutant), or mouse AhR (mAhR). Boxplots show data of 3 experiments. Statistical analysis: 2-way ANOVA with Tukey’s multiple comparisons test. * p-value < 0.05 vs. wt/AHR-1, # p-value < 0.05 vs. DMSO/EtOH.
Figure 7Proposed model of the AHR-1 signaling pathway in C. elegans response to pro- and antioxidants. In “normal” conditions (middle panel), AHR-1 is activated by intra-cellular ROS. This leads to the shedding of the chaperones from cytosolic AHR-1 and the subsequent nuclear translocation of AHR-1. In the nucleus, AHR-1 forms a heterodimer with the AHR nuclear translocator (AHA-1) and bind to XREs of target genes, which in turn leads to the reduction in intracellular ROS levels. In these conditions, loss of ahr-1 function leads to an increased lifespan. In the presence of antioxidants (left panel) the intra-cellular ROS concentrations are low leading to AHR-1 residing in the cytoplasm, bound by its cofactors. The inhibition of the basal AHR-1 activity leads to an increased lifespan. In the presence of pro-oxidants (right panel) AHR-1 is activated by excessive ROS, which results its nuclear translocation, the AHR-1–AHA-1 heterodimer formation and the initiation of target gene transcription. In the ahr-1 KO, the decreased detoxification of ROS through AHR-1-induced target genes leads to an accumulation of ROS and renders the ahr-1 KO susceptible.